RenaissThera is proud to participate in the 22nd edition of BioAsia 2025, the premier global life sciences and healthcare event, taking place at the Hyderabad International Convention Centre (HICC) on February 25-26, 2025.

Representing RenaissThera at this prestigious event will be Dr. Ramkesh Meena, Praful Gupta, and Sheetal Chauhan, who will engage with global industry leaders, healthcare innovators, and investor community to explore the future of AI-driven therapies.

This year’s theme “Catalysts of Change - Expanding Global Health Frontiers”, underscores the pivotal role of innovation in transforming global healthcare. At RenaissThera, we are committed to pioneering affordable innovative small molecule therapies powered by GenAI to address critical health challenges and increase access globally, particularly in the treatment of Diabetes Type 2 and Obesity.

Why Meet RenaissThera at BioAsia 2025?

• Revolutionary AI-Powered Therapies : Discover how we are leveraging AI-driven platforms to develop novel, and affordable small-molecule targeted therapies.
• Collaborative Innovation: Engage with our leaders to explore partnership opportunities aimed at accelerating drug discovery and enhancing patient outcomes.
• Investment Opportunity : Understand RenaissThera’s portfolio strategy and ambitions for potential collaboration to be part of the growth journey

Visit Us at Exhibition Booth- Stall No. 46

We invite you to meet our team to explore potential collaborations and discover how RenaissThera is making targeted therapies more affordable, effective, and accessible.

📍 Meet Us at | BioAsia 2025 | February 25-26, 2025 | Stall No. 46 |Hyderabad International Convention Centre (HICC)